MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.430
-0.100 (-6.54%)
At close: Jun 26, 2026, 4:00 PM EDT
1.430
0.00 (0.01%)
After-hours: Jun 26, 2026, 7:44 PM EDT
MetaVia Employees
MetaVia had 8 employees as of December 31, 2025. The number of employees decreased by 1 or -11.11% compared to the previous year.
Employees
8
Change (1Y)
-1
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,640,625
Market Cap
7.39M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| HCW Biologics | 35 |
| Bolt Biotherapeutics | 23 |
| AIM ImmunoTech | 21 |
| Imunon | 20 |
| Immuron | 7 |
| Ernexa Therapeutics | 7 |
| Kairos Pharma | 4 |
| Addex Therapeutics | 3 |
MTVA News
- 2 days ago - MetaVia Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 9 days ago - MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum - PRNewsWire
- 15 days ago - MetaVia Transcript: Emerging Growth Conference 93 - Transcripts
- 18 days ago - MetaVia Transcript: AGM 2026 - Transcripts
- 18 days ago - MetaVia presents data at ADA supporting DA-1726, vanoglipel - TheFly
- 18 days ago - MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential - PRNewsWire
- 22 days ago - MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference - PRNewsWire
- 4 weeks ago - MetaVia’s DA-1726 shows efficacy in obesity and MASH presentations - TheFly